We report of a 75-year-old patient with stroke-like presentation, where cerebral imaging led to the diagnosis of a massive arteriovenous malformation (AVM) of the whole left hemisphere. We suggest considering AVM as a differential diagnosis in patients with symptoms of acute stroke despite age and, in the absence of contraindications, in this setting to obtain MRI or CT angiography of the brain.

In patients with symptoms of acute stroke, diagnostic measures do not have to be taken only to exclude hemorrhagic stroke. Arteriovenous malformation (AVM) is an etiology that can mimic acute ischemic or hemorrhagic stroke. In view of that, computed tomography (CT) angiography of the brain has to be obtained, as cranial CT without angiography could lead to intravenous fibrinolysis. In patients with AVM, who have an elevated risk of intracerebral bleeding, this could lead to fatal outcome.

A 75-year-old patient was assigned to our emergency department with acute onset aphasia and reduced strength in the right arm and leg. Clinical examination showed a right sided hemiparesis and hemihypesthesia, a neglect to the right and global aphasia. The tendon reflexes were brisk. Furthermore, orientation was impaired. Suspected diagnosis was ischemic stroke with possible epileptic component due to myoclonia in the upper extremities of the patient. Intravenous diazepam was administered.

His medical history revealed resection of urothelial carcinoma without relapse, chronic renal insufficiency, diabetes mellitus type 2, and peripheral and coronary artery disease with quadruple aorto-coronary bypass several years previously.

CT angiography of the brain and neck was performed, showing unexpected, in consideration of the patient’s age, massive AVM of the left hemisphere with drainage to the superior sagittal sinus (Fig. 1). There were no signs of cerebral ischemia or bleeding. According to these findings, the planned fibrinolysis was cancelled due to the high risk of intracerebral bleeding.

Fig. 1.

Extensive arteriovenous malformation of left hemisphere with multiple aneurismatic extensions and expansion from the brainstem to the whole left hemisphere; accentuation in the left visual cortex.

Fig. 1.

Extensive arteriovenous malformation of left hemisphere with multiple aneurismatic extensions and expansion from the brainstem to the whole left hemisphere; accentuation in the left visual cortex.

Close modal

The patient was transferred to the ICU. An electroencephalogram (Fig. 2) showed alpha activity on the right, epileptic focus with rhythmic delta activity, and several suspected epileptic discharges frontotemporal and frontocentral on the left. No status epilepticus could be detected. An anti-epileptic therapy with levetiracetam was started and subsequently sensory as well as motor deficits and aphasia disappeared.

Fig. 2.

EEG: normal alpha rhythm on the right; focal slowing on the left.

Fig. 2.

EEG: normal alpha rhythm on the right; focal slowing on the left.

Close modal

The next day, MRI was carried out, confirming a huge AVM of the whole left hemisphere. The nidus was suspected in the left visual cortex with perifocal gliosis as an expression of a chronic steal phenomenon and eventual pseudoaneurysm in the left-sided basal ganglia (Fig. 3, 4). Blood supply was provided by the posterior cerebral artery and M1 branch of the middle cerebral artery. No tumors were detected. Progressive aneurismatic dilatation within the AVM was postulated as the cause of the acute onset of symptoms.

Fig. 3.

MRI with depiction of extensive arteriovenous malformation of the left hemisphere.

Fig. 3.

MRI with depiction of extensive arteriovenous malformation of the left hemisphere.

Close modal
Fig. 4.

MRI with depiction of extensive arteriovenous malformation of the nidus in the left visual cortex.

Fig. 4.

MRI with depiction of extensive arteriovenous malformation of the nidus in the left visual cortex.

Close modal

The remainder of his stay in the ICU was unremarkable, and the patient was discharged to the neurological ward with permanent anti-epileptic therapy. Later, the patient was assigned to the hospital reference center for evaluation of further treatment.

AVM are congenital vascular lesions, characterized by an atypical aggregation of dilated arteries and veins. These malformations arise from a deficient structure of blood vessels and a lack of capillaries. The exact pathological mechanisms are not yet fully understood. Severe clinical manifestations only occur in the brain [1].

The cause of AVM is most likely a high variability of hemodynamic forces. Furthermore, it is assumed that within this variability epigenetic factors in endothelial cells are being triggered. This causes a change in development and finally an aberration of the phenotype of blood vessels [1]. The average age for the diagnosis is 31.2 years, with a similar spread to both sexes. The symptoms that lead to further testing for AVM are most commonly epileptic seizures, focal-neurologic deficits, or headaches [2].

AVM are often graded after the Spetzler-Martin classification that separates six degrees of severity, with grade I being small, superficial, and located in a noneloquent part of the cortex and grade VI being inoperable [3]. This grading system evaluates the risk of surgical resection. In our case, Spetzler-Martin grade II in an eloquent area of the brain was diagnosed.

With microsurgery, a complete obliteration can be achieved in 96% of all cases. If surgical resection is not feasible or contraindicated, radiotherapy is a safe and effective alternative [4]. Radiotherapy can achieve complete obliteration in 40% of all cases [5]. A third option is endovascular embolization. On its own it often does not provide complete obliteration. Therefore, endovascular obliteration is mainly used to support and facilitate microsurgical resection [5]. In conclusion, microsurgical resection remains the gold standard in the treatment of AVM with increasing evidence that radiotherapy is an efficient alternative [6].

Concerning prognosis, a meta-analysis reported a case fatality of 1.1 per 100 patient-years with similar mortality rates after microsurgical resections and endovascular embolization. Mortality among patients that were treated with radiotherapy was only half as high. Male sex, drainage solely through the deep veins, and smaller AVM seemed to be protective factors [5].

Though most of the patients with AVM are young when diagnosis is made there are also patients becoming symptomatic only in older age, as in our case. A multicenter study [7] showed that 65% of all AVM of patients over 60 years were treated with microsurgery, supported by preoperative embolization in 1 out of 3 cases. Radiosurgery, embolization only, or a conservative approach was each chosen as therapy regimen in 10% of all cases. Patients who received microsurgical resection showed (distinct) best outcome. In 2 out of 3 cases, regardless of treatment regimen, a satisfactory outcome was achieved. After interventional treatment of AVM, age is not a risk factor for subsequent hemorrhage [8]. In untreated AVM age has been proposed as a risk factor for hemorrhage, with some studies showing older age [9] and others showing younger age [10] to be associated with higher risk of hemorrhage.

In the literature, there are several descriptions of first diagnosis of AVM in younger patients. Surprisingly, in our case the patient did not show any symptoms until an advanced age despite the huge size of AVM. To our knowledge, the age of our patient combined with the expanse of the AVM are unique.

Given the symptoms the patient presented, the main suspected diagnoses at this age were ischemic or hemorrhagic stroke, epileptic seizures, hypoglycemia, abscess, or tumor of the central nervous system [11]. Neuroimaging plays an important role in the differential diagnosis of neurological events with regard to treatment and improvement of outcome. Plain cranial CT scan (without contrast) is the most commonly used form of neuroimaging carried out in the emergency unit in the case of acute neurological symptoms resembling stroke. Although this technique is sufficient to recognize contraindications for fibrinolysis [11], it is essential to obtain CT angiography to detect other etiologies, such as AVM, and to avoid fibrinolysis which would increase the risk for intracerebral bleeding and fatal outcome.

The case described above shows that AVM should be considered as a differential diagnosis in patients with symptoms of acute stroke despite age. The performance of CT angiography is an essential first diagnostic tool to improve diagnostic accuracy and outcome.

Author Mathias Bürki would like to offer special thanks to the Bürgerspital Solothurn, and in particular the ICU, for the education he was given and to his wife Natalie and son Ryan for their never-ceasing support.

The trial was conducted in accordance with the Declaration of Helsinki and its amendments. For the actual case it was not necessary to involve the ethics committees, and the patient provided written informed consent before inclusion in the study.

The authors declare that they have no financial or nonfinancial competing interests regarding this paper. No funding was received for this study.

Conception and design of study: Mathias Bürki and Dr. Marcos Delgado. Acquisition of data: Mathias Bürki, Dr. Marcos Delgado, and Dr. Robert Bühler. Analysis and/or interpretation of data: Mathias Bürki, Dr. Marcos Delgado, and Dr. Liliane Kappeler. Drafting the manuscript: Mathias Bürki. Revising the manuscript critically for important intellectual content: Dr. Marcos Delgado and Dr. Liliane Kappeler. All authors gave their approval of the version of the manuscript to be published.

1.
Thomas
JM
,
Surendran
S
,
Abraham
M
,
Rajavelu
A
,
Kartha
CC
.
Genetic and epigenetic mechanisms in the development of arteriovenous malformations in the brain
.
Clin Epigenetics
.
2016
Jul
;
8
(
1
):
78
.
[PubMed]
1868-7075
2.
Hofmeister
C
,
Stapf
C
,
Hartmann
A
,
Sciacca
RR
,
Mansmann
U
,
terBrugge
K
, et al
Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation
.
Stroke
.
2000
Jun
;
31
(
6
):
1307
10
.
[PubMed]
0039-2499
3.
Spetzler
RF
,
Martin
NA
.
A proposed grading system for arteriovenous malformations
.
J Neurosurg
.
1986
Oct
;
65
(
4
):
476
83
.
[PubMed]
0022-3085
4.
Starke
RM
,
Yen
CP
,
Ding
D
,
Sheehan
JP
.
A practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients
.
J Neurosurg
.
2013
Oct
;
119
(
4
):
981
7
.
[PubMed]
0022-3085
5.
van Beijnum
J
,
van der Worp
HB
,
Buis
DR
,
Al-Shahi Salman
R
,
Kappelle
LJ
,
Rinkel
GJ
, et al
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis
.
JAMA
.
2011
Nov
;
306
(
18
):
2011
9
.
[PubMed]
0098-7484
6.
Conger
A
,
Kulwin
C
,
Lawton
MT
,
Cohen-Gadol
AA
.
Diagnosis and evaluation of intracranial arteriovenous malformations
.
Surg Neurol Int
.
2015
May
;
6
(
1
):
76
.
[PubMed]
2229-5097
7.
Tong
X
,
Wu
J
,
Lin
F
,
Cao
Y
,
Zhao
Y
,
Ning
B
, et al
Brain arteriovenous malformations in elderly patients: clinical features and treatment outcome
.
Acta Neurochir (Wien)
.
2015
Oct
;
157
(
10
):
1645
53
.
[PubMed]
0001-6268
8.
Rutledge
WC
,
Ko
NU
,
Lawton
MT
,
Kim
H
.
Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations
.
Transl Stroke Res
.
2014
Oct
;
5
(
5
):
538
42
.
[PubMed]
1868-4483
9.
Stapf
C
,
Mast
H
,
Sciacca
RR
,
Choi
JH
,
Khaw
AV
,
Connolly
ES
, et al
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation
.
Neurology
.
2006
May
;
66
(
9
):
1350
5
.
[PubMed]
0028-3878
10.
Yamada
S
,
Takagi
Y
,
Nozaki
K
,
Kikuta
K
,
Hashimoto
N
.
Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations
.
J Neurosurg
.
2007
Nov
;
107
(
5
):
965
72
.
[PubMed]
0022-3085
11.
Jauch
EC
,
Saver
JL
,
Adams
HP
 Jr
,
Bruno
A
,
Connors
JJ
,
Demaerschalk
BM
, et al;
American Heart Association Stroke Council
;
Council on Cardiovascular Nursing
;
Council on Peripheral Vascular Disease
;
Council on Clinical Cardiology
.
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
.
Stroke
.
2013
Mar
;
44
(
3
):
870
947
.
[PubMed]
0039-2499
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.